Pharmacist Intervention in Outpatients With Prostate Cancer Prevents Apalutamide-induced Skin Adverse Events
As far as we are aware, our study is the first to show that intervention by pharmacist outpatient clinics reduces apalutamide-induced sAEs. Pharmacist outpatient clinics can assist in the appropriate skin management of patients taking apalutamide.
Authors
- Toru Harabayashi (ORCID: https://orcid.org/0000-0002-5839-2954)
- Kengo Umehara
- Kayo Yamagishi
- Norikata Takada
- Hirokazu Hashishita
- Satoru Maruyama
- Yoshitaka Saito (ORCID: https://orcid.org/0009-0004-9821-7917)
- Shinya Takada (ORCID: https://orcid.org/0000-0002-6845-5533)
Institutions
- Hokkaido University of Science (JP)
- Hokkaido Pharmaceutical University (JP)
- National Hospital Organization Hokkaido Medical Center (JP)
- Sapporo National Hospital (JP)
Publication Details
- Journal
- In Vivo
- Published
- 2024-12-31
- DOI
- https://doi.org/10.21873/invivo.13849
- Citations
- 1
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.42